You Wan

You Wan

Auto-generated profile, based on publicly available information

You Wan

Neuroscience Research Institute, Peking University, Beijing, China

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 June 2024 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
PDF file
BCBo Cao
Bo Cao
QXQixuan Xu
Qixuan Xu
YSYajiao Shi
Yajiao Shi
RZRuiyang Zhao
Ruiyang Zhao
HLHanghang Li
Hanghang Li
BWBo Wei
Bo Wei
Pain is estimated to affect more than 20% of the global population, imposing incalculable health and economic burdens. Effective pain management is crucial for individuals suffering from pain. However, the current methods for pain assessment and treatment fall short of clinical needs. Benefiting from advances in neuroscience and biotechnology, the neuronal circuits and molecular mechanisms critically involved in pain modulation have been elucidated. These research achievements have incited progress in identifying new diagnostic and therapeutic targets. In this review, we first introduce fundamental knowledge about pain, setting the stage for the subsequent contents. The review next delves into the molecular mechanisms underlying pain disorders, including gene mutation, epigenetic modification, posttranslational modification, inflammasome, signaling pathways and microbiota. To better present a comprehensive view of pain research, two prominent issues, sexual dimorphism and pain comorbidities, are discussed in detail based on current findings. The status quo of pain evaluation and manipulation is summarized. A series of improved and innovative pain management strategies, such as gene therapy, monoclonal antibody, brain-computer interface and microbial intervention, are making strides towards clinical application. We highlight existing limitations and future directions for enhancing the quality of preclinical and clinical research. Efforts to decipher the complexities of pain pathology will be instrumental in translating scientific discoveries into clinical practice, thereby improving pain management from bench to bedside.

1 January 2011 in Neurobiology of Aging
Verified
Journal Article
Closed access
ZTZhiqian Tong
Zhiqian Tong
JZJinling Zhang
Jinling Zhang
WLWenhong Luo
Wenhong Luo
WWWeishan Wang
Weishan Wang
FLFangxu Li
Fangxu Li
RHRongqiao He
Rongqiao He

1 January 2008 in Molecular Pain
Verified
Journal Article
Open access
LYLu Yu
Lu Yu
FYFei Yang
Fei Yang
HLHao Luo
Hao Luo
FLFeng-Yu Liu
Feng-Yu Liu
JHJi-Sheng Han
Ji-Sheng Han
YWYou Wan
You Wan
Background: The present study aims to investigate the role of transient receptor potential vanilloid 1 (TRPV1) in dorsal root ganglion (DRG) neurons in chronic pain including thermal hyperalgesia and mechanical allodynia. Chronic inflammatory nociception of rats was produced by intraplantar injection of complete Freund's adjuvant (CFA) and data was collected until day 28 following injection.Results: Thermal hyperalgesia was evident from day 1 to day 28 with peak at day 7, while mechanical allodynia persisted from day 1 to day 14 and was greatest at day 7. Intrathecal administration of AMG 9810 at day 7, a selective TRPV1 antagonist, significantly reduced thermal hyperalgesia and mechanical allodynia. TRPV1 expression in DRG detected by Western blotting was increased relative to baseline throughout the observation period. Double labeling of TRPV1 with neuronal marker neurofilament 200 (NF200), calcitonin gene-related peptide (CGRP) or isolectin B4 (IB4) was used to distinguish different subtypes of DRG neurons. TRPV1 expression was increased in the medium-sized myelinated A fiber (NF200 positive) neurons and in small non-peptidergic (IB4 positive) neurons from day 1 to day 14 and was increased in small peptidergic (CGRP positive) neurons from day 1 to day 28.Conclusion: TRPV1 expression increases in all three types of DRG neurons after CFA injection and plays a role in CFA-induced chronic inflammatory pain including thermal hyperalgesia and mechanical allodynia.

1 May 2002 in Pain
Verified
Journal Article
Closed access
WLWilliam R. Lariviere
William R. Lariviere
SWSonya G. Wilson
Sonya G. Wilson
TLTinna M. Laughlin
Tinna M. Laughlin
AKAnna Kokayeff
Anna Kokayeff
EWErin E. West
Erin E. West
JMJeffrey S. Mogil
Jeffrey S. Mogil
We and others have previously demonstrated that nociception in the mouse is heritable. A genetic correlation analysis of 12 common measures of nociception among a common set of inbred strains revealed three major clusters (or 'types') of nociception in this species. In the present study, we re-evaluated the major types of nociception and their interrelatedness using ten additional assays of nociception and hypersensitivity, including: three thermal assays (tail withdrawal from 47.5 degrees C water or -15 degrees C ethanol; tail flick from radiant heat), two chemical assays of spontaneous nociception (bee venom test; capsaicin test) and their subsequent thermal hypersensitivity states (including contralateral hypersensitivity in the bee venom test), a mechanical nociceptive assay (tail-clip test), and a mechanical hypersensitivity assay (intrathecal dynorphin). Confirming our earlier findings, the results demonstrate distinct thermal and chemical nociceptive types. It is now clear that mechanical hypersensitivity and thermal hypersensitivity are genetically dissociable phenomena. Furthermore, we now see at least two distinct types of thermal hypersensitivity: afferent-dependent, featuring a preceding significant period of spontaneous nociceptive behavior associated with afferent neural activity, and non-afferent-dependent. In conclusion, our latest analysis suggests that there are at least five fundamental types of nociception and hypersensitivity: (1) baseline thermal nociception; (2) spontaneous responses to noxious chemical stimuli; (3) thermal hypersensitivity; (4) mechanical hypersensitivity; and (5) afferent input-dependent hypersensitivity.

1 February 2009 in Experimental Neurology
Verified
Journal Article
Closed access
XQXiao-Xiu Qu
Xiao-Xiu Qu
JCJie Cai
Jie Cai
MLMing-Jia Li
Ming-Jia Li
YCYe-Nan Chi
Ye-Nan Chi
FLFei-Fei Liao
Fei-Fei Liao
GXGuo-Gang Xing
Guo-Gang Xing

1 April 2010 in Experimental Neurology
Verified
Journal Article
Closed access
SGShan-Jing Geng
Shan-Jing Geng
FLFei-Fei Liao
Fei-Fei Liao
WDWen-Hao Dang
Wen-Hao Dang
XDXu Ding
Xu Ding
XLXiao-Dan Liu
Xiao-Dan Liu
GXGuo-Gang Xing
Guo-Gang Xing